AMRx
Innominds Software Inc. · Intelligence & Research
Certification per AWS Marketplace.
Evidence tier Source Confirmed · 4 captures on record
What the publisher says
As described on AWS Marketplace.
AMRx is an innovative culture-free, sample-free diagnostic tool for detecting urinary tract infections (UTIs) and antibiotic resistance patterns. While traditional methods rely on laboratory cultures and require 48+ hours, AMRx delivers instant results with proven accuracy, validated in seven tertiary care hospitals. This rapid, precise approach reduces diagnostic delays, optimizes antibiotic use, and helps combat antimicrobial resistance, an escalating global health threat.
AMRx stands out as a pioneering solution in the realm of urinary tract infection (UTI) diagnostics, offering a range of unique features that enhance its effectiveness and usability in modern healthcare settings.
Show the rest of the publisher’s description (16 more lines)
Unique Features of AMRx Technology:
a) Patented, Culture-Free Diagnostic Approach: AMRx revolutionizes UTI diagnostics by eliminating the need for traditional culture tests. It utilizes patient clinical history to:
Accurately predict UTIs based on clinical data without relying on time-consuming cultures.
Identify causative organisms such as Enterobacteriaceae.
Determine antibiotic resistance patterns, enabling precise and targeted treatment.
b) Efficient and Resource-Saving:
Reduces unwarranted investigations, saving time and resources.
Beneficial in resource-limited settings where rapid and accurate diagnostics are crucial.
c) Clinical Decision Support:
Aids empirical antibiotic prescriptions by predicting resistance patterns.
Improves treatment outcomes by guiding precise antibiotic use.
d) Early Prognosis and Treatment:
Provides rapid results for early detection of infections.
Enables timely treatment, improving patient outcomes and reducing spread of resistant bacteria.
e) Seamless Interoperability:
Integrates with Electronic Medical Record (EMR) systems, ensuring diagnostic results are accessible and actionable within clinical workflows
Highlights
Highlighted by the publisher on AWS Marketplace.
Predict Infections and Resistance Patterns: Utilize advanced artificial intelligence and machine learning algorithms to analyze patient data and predict infection types and antibiotic resistance patterns in real time.
Enhance Prescription Accuracy: Assist clinicians in prescribing the most appropriate antibiotic for each patient promptly, thereby reducing the reliance on broad spectrum antibiotics and minimizing inappropriate use.
Combat AMR Effectively: By providing accurate predictions and recommendations, the tool aims to curb the irrational use of antibiotics, thereby directly contributing to the fight against AMR.
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Plans and pricing as listed
1 listed- Units
Refund terms
As stated by the publisher on AWS Marketplace.
All sales are finale. Refund will be paid based on technical review and validations. For assistance, please contact aws-apn@innominds.com
Sources
Publisher resources
1 linkLinked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.